Cysteine

Cysteine

SCHEMBL4023815

C=CC(=O)O.NC(CS)C(=O)O

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.73
SLC7A11 Q9UPY5 1/20 0.73
LMNA P02545 1/20 0.46
ENPEP Q07075 6/20 0.45
GRIK1 P39086 6/20 0.44
GRIK2 Q13002 6/20 0.44
GRM1 Q13255 2/20 0.40
GRM2 Q14416 2/20 0.40
GSR P00390 2/20 0.38
SLC7A5 Q01650 1/20 0.38
GRM8 O00222 1/20 0.38
GRM6 O15303 1/20 0.38
GRIN2D O15399 1/20 0.38
GRIN3B O60391 1/20 0.38
CYP1A2 P05177 1/20 0.38
GRM5 P41594 1/20 0.38
GRIA1 P42261 1/20 0.38
GRIA2 P42262 1/20 0.38
GRIA3 P42263 1/20 0.38
SLC1A3 P43003 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cysteine SCHEMBL4023819 1.00 PTGS1 (0.73) PTGS1SLC7A11LMNAENPEPGRIK1
Cysteine SCHEMBL28283554 0.89 PTGS1 (0.70) PTGS1SLC7A11ENPEPGRIK1GRIK2
Cysteine SCHEMBL4245391 0.89 PTGS1 (0.70) PTGS1SLC7A11ENPEPGRIK1GRIK2
Cysteine SCHEMBL1276081 0.89 PTGS1 (0.70) PTGS1SLC7A11ENPEPGRIK1GRIK2
Cysteine SCHEMBL28192928 0.86 PTGS1 (0.73) PTGS1SLC7A11ENPEPGRIK1GRIK2
Cysteine SCHEMBL1819437 0.85 PTGS1 (0.89) PTGS1SLC7A11ENPEPGRIK1GRIK2
Cysteine SCHEMBL27530294 0.85
Cysteine SCHEMBL5831493 0.85
Cysteine SCHEMBL1819440 0.85 PTGS1 (0.89) PTGS1SLC7A11ENPEPGRIK1GRIK2
Cysteine SCHEMBL1868335 0.85 PTGS1 (1.00) PTGS1SLC7A11ENPEPGRIK1GRIK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104507458-A Mucoadhesive nanoparticle delivery system GU FRANK 2015-04-08 CN disclosed
US-20090041816-A1 Coated particles CONOPCO, INC. D/B/A UNILEVER 2009-02-12 US disclosed
WO-2009016091-A1 COATED PARTICLES UNILEVER PLC (GB) 2009-02-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090041816-A1 Coated particles LIPA, PLIN3, APOB PTGS1 4466/4885SLC7A11 4823/4885LMNA 574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.